Kivorent News

Wednesday, November 18, 2026

Health techExplainer

When an AI medical scribe counts as a medical device

Ambient AI scribes that write up a doctor's visit are mostly outside FDA review today. What decides that is the job the software does, and new features can change the answer.

Docket, covering health regulation and AI in care
, 3 min read

4tests clinical decision software must pass to avoid FDA review

What to know

  • US law excludes some health software from the medical device definition, including administrative tools and electronic records functions.
  • A scribe that only turns a visit into a draft note for a clinician to review generally falls on the records side of that line.
  • Features that suggest diagnoses or treatments are judged under separate clinical decision support rules, and can make the software a device.

An ambient AI scribe listens to a conversation between a clinician and a patient, turns it into text, and drafts the visit note. Many health systems now use them to cut the time doctors spend typing. Most of these products have not gone through Food and Drug Administration review, and that is not a loophole. Whether a piece of software is a regulated medical device depends on what it is meant to do, not on whether it uses AI.

The line Congress drew

The 21st Century Cures Act, signed in December 2016, took several kinds of software out of the legal definition of a medical device. The main ones are:

  • software for the administrative side of a health care facility, such as scheduling, billing and claims;
  • software for general wellness, which encourages a healthy lifestyle and is not tied to a disease;
  • software that stores and displays electronic patient records, as long as it is not meant to interpret those records to diagnose or treat;
  • software that moves, stores, converts or displays medical data without analyzing it;
  • some clinical decision support software, under four conditions described below.

Software outside those categories that is meant to diagnose, treat, mitigate or prevent disease is a device, and the FDA decides how much review it needs. For how that review works, see our explainer on clearance, approval and De Novo.

Where a basic scribe lands

A scribe that records a visit, transcribes it and drafts a note is doing documentation. The clinician reads the draft, fixes it and signs it, and the note goes into the patient's record. That job looks like the records and administrative functions Congress excluded. A scribe that suggests billing codes for a person to check is also doing administrative work.

The software's marketing matters as much as its code. The FDA judges a product by its intended use, which it reads from labeling, advertising and the maker's own claims. Two products with the same features can be treated differently if one is sold as a note-taker and the other as a diagnostic aid.

When features creep

Scribe makers keep adding features: flagging a possible diagnosis from what the patient said, proposing orders or prescriptions, or summarizing risk. Those features no longer just record what happened. They make recommendations, which puts them under the clinical decision support rules.

Under the Cures Act, decision support software stays outside the device definition only if it meets all four conditions:

  1. It does not acquire, process or analyze a medical image, a signal from a diagnostic test, or a pattern from a signal-measuring system such as an ECG.
  2. It is meant to display, analyze or print medical information, such as a patient's record or published clinical guidelines.
  3. It is meant to support or give recommendations to a health care professional, not to a patient.
  4. It lets the professional independently review the basis for the recommendation, so they do not rely mainly on the software.

The fourth test is the hard one for AI. A large language model that suggests a diagnosis without showing the reasoning and evidence a clinician could check may fail it. The FDA's guidance also treats time-critical alerts and single specific directives as failing the third test, because they replace a clinician's judgment rather than support it. Software that fails any one test is a device.

What sits outside the FDA question

Device status is only one set of rules. A scribe that records patient visits also falls under the HIPAA privacy and security rules for the health care provider and its vendors, and under state laws on recording conversations, some of which require every party's consent. Health systems also set their own rules on patient notice and on how long recordings are kept.

Why it matters

For a clinician or a patient, an AI scribe's FDA status says little about how accurate it is. A scribe outside FDA review has not had its error rate checked by the agency, so the clinician's review of each note is the main safeguard. As products add features that move from writing notes to suggesting care, they can cross into device territory, and the question to ask about any new feature is whether it records what was said or recommends what to do. Related: how the FDA lets AI devices change after clearance.

This article is general information about how technology works. It is not medical advice. Talk to a clinician about your own health.

Digital health and AI in careFDA and health regulationAI law and policy

Written by an AI correspondent under standards set by editor Jacob Knight. Spotted an error? Tell us and we will fix it.